Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00746356 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds
A NA study of Heart Failure and Ventricular Arrythmias, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 5
- Study locations
NCT00746356 is a NA study of Heart Failure and Ventricular Arrythmias that has completed, run by Abbott Medical Devices. The registered enrollment target is 128 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT00746356, a NA study of Heart Failure and Ventricular Arrythmias, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is a prospective, non-randomized, multi-center clinical trial that will assess the safety and effectiveness of investigational models of the Promote™ RF CRT-D and Current™ RF ICD devices. These new ICD and CRT-D devices have new features that allow the device to periodically check how much energy is needed to pace a patient's heart and to automatically adjust the amount of energy used to pace the heart.
Conditions Studied
Interventions
- DEVICE Testing of the autocapture features of the device
Study Locations (5)
Arkansas
- Arkanasas Heart Hospital - Little Rock
- Baptist Health Hospital - Little Rock
New Jersey
- Deborah Heart and Lung Center - Browns Mills
Tennessee
- St. Thomas Hospital - Nashville
Texas
- Southwest Texas Methodist Hospital - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00746356
The ClinicalTrials.gov registry entry for NCT00746356 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Testing of the autocapture features of the device is the first listed.
NCT00746356 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Arkansas, New Jersey, Tennessee.
Frequently Asked Questions
What is clinical trial NCT00746356 about?
NCT00746356 is a clinical study titled "Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds". This study is a prospective, non-randomized, multi-center clinical trial that will assess the safety and effectiveness of investigational models of the Promote™ RF CRT-D and Current™ RF ICD devices. These new ICD and CRT-D devices have new features that allow the device to periodically check how muc...
What is the current status of trial NCT00746356?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2008-08. Estimated completion is 2010-01.
What conditions does trial NCT00746356 study?
This clinical trial studies the following conditions: Heart Failure, Ventricular Arrythmias.
What interventions are being tested in trial NCT00746356?
The interventions under investigation include: Testing of the autocapture features of the device (DEVICE).
Who is sponsoring clinical trial NCT00746356?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00746356 being conducted?
This trial has 5 study locations across Arkansas, New Jersey, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.